Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James A. Elberling is active.

Publication


Featured researches published by James A. Elberling.


Biochemical Pharmacology | 1993

Nitroxyl analogs as inhibitors of aldehyde dehydrogenase: C-nitroso compounds

Herbert T. Nagasawa; Yul Yost; James A. Elberling; Frances N. Shirota; Eugene G. DeMaster

We previously postulated that the catalase-mediated oxidation of cyanamide leads to the formation of the unstable intermediate, N-hydroxycyanamide, which spontaneously decomposes to nitroxyl, the putative inhibitor of aldehyde dehydrogenase (EC 1.2.1.3; AlDH). Since it was not possible to provide direct evidence for the inhibition of AlDH by nitroxyl, we examined the activity of three representative substituted nitroxyls (C-nitroso compounds), viz. nitrosobenzene (NB), 1-nitrosoadamantane (NA), and 2-methyl-2-nitrosopropane (MNP), as direct inhibitors of yeast AlDH in vitro. While NB and NA were highly effective inhibitors in this system exhibiting IC50 values of 2.5 and 8.6 microM, respectively, MNP was considerably less effective with an IC50 of 0.15 mM. When tested in vivo, NA did not show any inhibitory activity on the hepatic AlDH, possibly due to the lack of site-specific delivery of the active monomeric form of this compound. However, NB at a low dose did inhibit hepatic AlDH as reflected by an increase in blood acetaldehyde levels. These results attest to the abilities of NB and NA to act as direct inhibitors of AlDH analogous to nitroxyl itself.


Journal of Medicinal Chemistry | 1995

Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-à-vis vascular smooth muscle relaxants

Herbert T. Nagasawa; Sagar P. Kawle; James A. Elberling; Eugene G. DeMaster; Jon M. Fukuto


Journal of Medicinal Chemistry | 1992

Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase

Melinda J.C. Lee; Herbert T. Nagasawa; James A. Elberling; Eugene G. DeMaster


Journal of Medicinal Chemistry | 1987

.beta.-Substituted cysteines as sequestering agents for ethanol-derived acetaldehyde in vivo

Herbert T. Nagasawa; James A. Elberling; Jeanette C. Roberts


Journal of Medicinal Chemistry | 1980

Structural requirements for the sequestration of metabolically generated acetaldehyde

Herbert T. Nagasawa; James A. Elberling; Eugene G. DeMaster


Journal of Medicinal Chemistry | 1973

2-Aminoadamantane-2-carboxylic acid, a rigid, achiral, tricyclic .alpha.-amino acid with transport inhibitory properties

Herbert T. Nagasawa; James A. Elberling; Frances N. Shirota


Journal of Medicinal Chemistry | 1989

N1-alkyl-substituted derivatives of chlorpropamide as inhibitors of aldehyde dehydrogenase

Herbert T. Nagasawa; James A. Elberling; Eugene G. DeMaster; Frances N. Shirota


Journal of Medicinal Chemistry | 1980

Metabolic depropargylation and its relationship to aldehyde dehydrogenase inhibition in vivo.

Frances N. Shirota; Eugene G. DeMaster; James A. Elberling; Herbert T. Nagasawa


Journal of Medicinal Chemistry | 2000

N-Terminal dipeptides of D(-)-penicillamine as sequestration agents for acetaldehyde.

Jonathan F. Cohen; James A. Elberling; Eugene G. DeMaster; Renee C. Lin; Herbert T. Nagasawa


Journal of Medicinal Chemistry | 1992

N1-Hydroxylated derivatives of chlorpropamide and its analogs as inhibitors of aldehyde dehydrogenase in vivo

Melinda J.C. Lee; James A. Elberling; Herbert T. Nagasawa

Collaboration


Dive into the James A. Elberling's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frances N. Shirota

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge